Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Galán B[au]:

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. ADVANCE Collaborative Group. et al. N Engl J Med. (2008)

Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes. Ratter JM et al. Diabetes. (2017)

Severe hypoglycemia and risks of vascular events and death. Zoungas S et al. N Engl J Med. (2010)

Search results

Items: 1 to 50 of 163

1.

Sweet dreams or bitter nightmare: a narrative review of 25 years of research on the role of sleep in diabetes and the contributions of behavioural science.

Nefs G, Bazelmans E, Donga E, Tack CJ, de Galan BE.

Diabet Med. 2019 Dec 12. doi: 10.1111/dme.14211. [Epub ahead of print]

PMID:
31833083
2.

Genome of Labrenzia sp. PHM005 Reveals a Complete and Active Trans-AT PKS Gene Cluster for the Biosynthesis of Labrenzin.

Kačar D, Schleissner C, Cañedo LM, Rodríguez P, de la Calle F, Galán B, García JL.

Front Microbiol. 2019 Nov 7;10:2561. doi: 10.3389/fmicb.2019.02561. eCollection 2019.

3.

Açai pulp supplementation as a nutritional strategy to prevent oxidative damage, improve oxidative status, and modulate blood lactate of male cyclists.

Terrazas SIBM, Galan BSM, De Carvalho FG, Venancio VP, Antunes LMG, Papoti M, Toro MJU, da Costa IF, de Freitas EC.

Eur J Nutr. 2019 Nov 13. doi: 10.1007/s00394-019-02138-7. [Epub ahead of print]

PMID:
31724083
4.

Testosterone Degradative Pathway of Novosphingobium tardaugens.

Ibero J, Galán B, Díaz E, García JL.

Genes (Basel). 2019 Oct 31;10(11). pii: E871. doi: 10.3390/genes10110871.

5.

RT-CGM in adults with type 1 diabetes improves both glycaemic and patient-reported outcomes, but independent of each other.

Nefs G, Bazelmans E, Marsman D, Snellen N, Tack CJ, de Galan BE.

Diabetes Res Clin Pract. 2019 Oct 31;158:107910. doi: 10.1016/j.diabres.2019.107910. [Epub ahead of print]

PMID:
31678626
6.

Transposons played a major role in the diversification between the closely related almond and peach genomes: results from the almond genome sequence.

Alioto T, Alexiou KG, Bardil A, Barteri F, Castanera R, Cruz F, Dhingra A, Duval H, Fernández I Martí Á, Frias L, Galán B, García JL, Howad W, Gómez-Garrido J, Gut M, Julca I, Morata J, Puigdomènech P, Ribeca P, Rubio Cabetas MJ, Vlasova A, Wirthensohn M, Garcia-Mas J, Gabaldón T, Casacuberta JM, Arús P.

Plant J. 2019 Sep 16. doi: 10.1111/tpj.14538. [Epub ahead of print]

PMID:
31529539
7.

[Checkpoint inhibitor induced diabetes mellitus].

Leentjens J, Bekkink MO, Koot R, Herbschleb KH, de Galan BE.

Ned Tijdschr Geneeskd. 2019 Aug 19;163. pii: D3726. Dutch.

PMID:
31433147
8.

SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.

de Wit L, Rademaker D, Voormolen DN, Akerboom BMC, Kiewiet-Kemper RM, Soeters MR, Verwij-Didden MAL, Assouiki F, Schippers DH, Vermeulen MAR, Kuppens SMI, Oosterwerff MM, Zwart JJ, Diekman MJM, Vogelvang TE, Gallas PRJ, Galjaard S, Visser W, Horree N, Klooker TK, Laan R, Heijligenberg R, Huisjes AJM, van Bemmel T, van Meir CA, van den Beld AW, Hermes W, Vidarsdottir S, Veldhuis-Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Potter van Loon BJ, van der Heijden OWH, de Galan BE, van Leeuwen M, Wijbenga JAM, de Boer K, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Wouters MGAJ, IJzerman RG, Mensing van Charante NA, Zwertbroek R, Bosmans JE, Evers IM, Mol BW, de Valk HW, Groenendaal F, Naaktgeboren CA, Painter RC, deVries JH, Franx A, van Rijn BB.

BMJ Open. 2019 Aug 18;9(8):e029808. doi: 10.1136/bmjopen-2019-029808.

9.

Clinical impact of artifactual hypoglycaemia and its diagnosis at the bedside.

Drenthen LCA, Verheggen RJHM, de Galan BE.

Rheumatology (Oxford). 2019 Sep 1;58(9):1691-1692. doi: 10.1093/rheumatology/kez118. No abstract available.

10.

Identification and expression of the 11β-steroid hydroxylase from Cochliobolus lunatus in Corynebacterium glutamicum.

Felpeto-Santero C, Galán B, Luengo JM, Fernández-Cañon JM, Del Cerro C, Medrano FJ, García JL.

Microb Biotechnol. 2019 Sep;12(5):856-868. doi: 10.1111/1751-7915.13428. Epub 2019 Jun 14.

11.

PET imaging during hypoglycaemia to study adipose tissue metabolism.

Boss M, Rooijackers HMM, Buitinga M, Janssen MJR, Arens AIJ, de Geus-Oei LF, Salm LP, de Galan BE, Gotthardt M.

Eur J Clin Invest. 2019 Jul;49(7):e13120. doi: 10.1111/eci.13120. Epub 2019 Apr 29.

12.

Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status.

Wiegers EC, Rooijackers HM, van Asten JJA, Tack CJ, Heerschap A, de Galan BE, van der Graaf M.

Diabetologia. 2019 Jun;62(6):1065-1073. doi: 10.1007/s00125-019-4862-9. Epub 2019 Apr 19.

13.

Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetes; a randomized controlled trial.

van Meijel LA, Rooijackers HM, Tack CJ, de Galan BE.

J Clin Endocrinol Metab. 2019 Apr 8. pii: jc.2019-00087. doi: 10.1210/jc.2019-00087. [Epub ahead of print]

PMID:
30958544
14.

High-Quality Whole-Genome Sequence of an Estradiol-Degrading Strain, Novosphingobium tardaugens NBRC 16725.

Ibero J, Sanz D, Galán B, Díaz E, García JL.

Microbiol Resour Announc. 2019 Mar 14;8(11). pii: e01715-18. doi: 10.1128/MRA.01715-18.

15.

Early Detection of Hypoglycemia in Type 1 Diabetes Using Heart Rate Variability Measured by a Wearable Device.

Olde Bekkink M, Koeneman M, de Galan BE, Bredie SJ.

Diabetes Care. 2019 Apr;42(4):689-692. doi: 10.2337/dc18-1843.

PMID:
30877089
16.

Effect of Dapagliflozin Treatment on the Expression of Renal Sodium Transporters/Channels on High-Fat Diet Diabetic Mice.

Ma C, de Baaij JHF, Millar PJ, Gault VA, de Galan BE, Bindels RJM, Hoenderop JGJ.

Nephron. 2019;142(1):51-60. doi: 10.1159/000496617. Epub 2019 Feb 22.

17.

In vitro and in vivo Effects of Lactate on Metabolism and Cytokine Production of Human Primary PBMCs and Monocytes.

Ratter JM, Rooijackers HMM, Hooiveld GJ, Hijmans AGM, de Galan BE, Tack CJ, Stienstra R.

Front Immunol. 2018 Nov 12;9:2564. doi: 10.3389/fimmu.2018.02564. eCollection 2018.

18.

Genetic determinants of impaired awareness of hypoglycemia in type 1 diabetes.

Schouwenberg BJ, de Galan BE.

Pharmacogenet Genomics. 2018 Aug;28(8):196-197. doi: 10.1097/FPC.0000000000000344. No abstract available.

PMID:
30169472
19.

Hypoglycaemia induces recruitment of non-classical monocytes and cytotoxic lymphocyte subsets in type 1 diabetes.

Ratter JM, Rooijackers HMM, Jacobs CWM, de Galan BE, Tack CJ, Stienstra R.

Diabetologia. 2018 Sep;61(9):2069-2071. doi: 10.1007/s00125-018-4683-2. Epub 2018 Jul 7. No abstract available.

PMID:
29982873
20.

New Insights on Steroid Biotechnology.

Fernández-Cabezón L, Galán B, García JL.

Front Microbiol. 2018 May 15;9:958. doi: 10.3389/fmicb.2018.00958. eCollection 2018. Review.

21.

Effect of lactate administration on brain lactate levels during hypoglycemia in patients with type 1 diabetes.

Wiegers EC, Rooijackers HM, Tack CJ, Philips BW, Heerschap A, van der Graaf M, de Galan BE.

J Cereb Blood Flow Metab. 2019 Oct;39(10):1974-1982. doi: 10.1177/0271678X18775884. Epub 2018 May 11.

22.

Unravelling a new catabolic pathway of C-19 steroids in Mycobacterium smegmatis.

Fernández-Cabezón L, Galán B, García JL.

Environ Microbiol. 2018 May;20(5):1815-1827. doi: 10.1111/1462-2920.14114. Epub 2018 Apr 24.

PMID:
29611894
23.

Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.

van Meijel LA, van den Heuvel-Bens SP, Zimmerman LJ, Bazelmans E, Tack CJ, de Galan BE.

Clin Ther. 2018 Jun;40(6):862-871. doi: 10.1016/j.clinthera.2018.02.004. Epub 2018 Mar 1.

24.

Outcomes of iontophoretic corneal collagen crosslinking in keratoconic eyes with very thin corneas.

Cantemir A, Alexa AI, Galan BG, Anton N, Ciuntu RE, Danielescu C, Chiselita D, Costin D.

Medicine (Baltimore). 2017 Nov;96(47):e8758. doi: 10.1097/MD.0000000000008758.

25.

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.

Lachmandas E, Thiem K, van den Heuvel C, Hijmans A, de Galan BE, Tack CJ, Netea MG, van Crevel R, van Diepen JA.

Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):371-380. doi: 10.1007/s10096-017-3145-y. Epub 2017 Nov 30.

26.

Iontophoretic collagen cross-linking versus epithelium-off collagen cross-linking for early stage of progressive keratoconus - 3 years follow-up study.

Cantemir A, Alexa AI, Galan BG, Anton N, Ciuntu RE, Danielescu C, Chiselita D, Costin D.

Acta Ophthalmol. 2017 Nov;95(7):e649-e655. doi: 10.1111/aos.13538.

27.

Taurine: A Potential Ergogenic Aid for Preventing Muscle Damage and Protein Catabolism and Decreasing Oxidative Stress Produced by Endurance Exercise.

De Carvalho FG, Galan BSM, Santos PC, Pritchett K, Pfrimer K, Ferriolli E, Papoti M, Marchini JS, de Freitas EC.

Front Physiol. 2017 Sep 20;8:710. doi: 10.3389/fphys.2017.00710. eCollection 2017.

28.

A cost-controlling treatment strategy of adding liraglutide to insulin in type 2 diabetes.

de Wit HM, Vervoort GMM, de Galan BE, Tack CJ.

Neth J Med. 2017 Sep;75(7):272-280.

29.

Effect of Exercise-Induced Lactate Elevation on Brain Lactate Levels During Hypoglycemia in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia.

Wiegers EC, Rooijackers HM, Tack CJ, Groenewoud HJMM, Heerschap A, de Galan BE, van der Graaf M.

Diabetes. 2017 Dec;66(12):3105-3110. doi: 10.2337/db17-0794. Epub 2017 Sep 21.

30.

Microalgae, old sustainable food and fashion nutraceuticals.

García JL, de Vicente M, Galán B.

Microb Biotechnol. 2017 Sep;10(5):1017-1024. doi: 10.1111/1751-7915.12800. Epub 2017 Aug 15. Review.

31.

Molecular and functional analysis of the mce4 operon in Mycobacterium smegmatis.

García-Fernández J, Papavinasasundaram K, Galán B, Sassetti CM, García JL.

Environ Microbiol. 2017 Sep;19(9):3689-3699. doi: 10.1111/1462-2920.13869. Epub 2017 Aug 24.

PMID:
28752922
32.

Effects of taurine on markers of muscle damage, inflammatory response and physical performance in triathletes.

Galan BS, Carvalho FG, Santos PC, Gobbi RB, Kalva-Filho CA, Papoti M, da Silva AS, Freitas EC.

J Sports Med Phys Fitness. 2018 Sep;58(9):1318-1324. doi: 10.23736/S0022-4707.17.07497-7. Epub 2017 Jul 25.

PMID:
28745470
33.

Bioconversion of Phytosterols into Androstadienedione by Mycobacterium smegmatis CECT 8331.

García-Fernández J, Martínez I, Fernández-Cabezón L, Felpeto-Santero C, García JL, Galán B.

Methods Mol Biol. 2017;1645:211-225. doi: 10.1007/978-1-4939-7183-1_15.

PMID:
28710631
34.

Genetic determinants of impaired awareness of hypoglycemia in type 1 diabetes.

Schouwenberg BJ, Coenen MJ, Paterson AD, Tack CJ, Smits P, Kramers C, de Galan BE.

Pharmacogenet Genomics. 2017 Sep;27(9):323-328. doi: 10.1097/FPC.0000000000000295.

PMID:
28692628
35.

Estuarine sediment resuspension and acidification: Release behaviour of contaminants under different oxidation levels and acid sources.

Martín-Torre MC, Cifrian E, Ruiz G, Galán B, Viguri JR.

J Environ Manage. 2017 Sep 1;199:211-221. doi: 10.1016/j.jenvman.2017.05.044. Epub 2017 May 22.

PMID:
28544927
36.

Unravelling the pleiotropic role of the MceG ATPase in Mycobacterium smegmatis.

García-Fernández J, Papavinasasundaram K, Galán B, Sassetti CM, García JL.

Environ Microbiol. 2017 Jul;19(7):2564-2576. doi: 10.1111/1462-2920.13771. Epub 2017 May 11.

PMID:
28447386
37.

A Single Bout of High-Intensity Interval Training Reduces Awareness of Subsequent Hypoglycemia in Patients With Type 1 Diabetes.

Rooijackers HM, Wiegers EC, van der Graaf M, Thijssen DH, Kessels RPC, Tack CJ, de Galan BE.

Diabetes. 2017 Jul;66(7):1990-1998. doi: 10.2337/db16-1535. Epub 2017 Apr 18.

38.

Pharmacokinetic and Pharmacodynamic Variability of Insulin When Administered by Jet Injection.

Engwerda EEC, Tack CJ, de Galan BE.

J Diabetes Sci Technol. 2017 Sep;11(5):947-952. doi: 10.1177/1932296817699638. Epub 2017 Mar 17.

39.

Molecular characterization of a new gene cluster for steroid degradation in Mycobacterium smegmatis.

Fernández-Cabezón L, García-Fernández E, Galán B, García JL.

Environ Microbiol. 2017 Jul;19(7):2546-2563. doi: 10.1111/1462-2920.13704. Epub 2017 Mar 26.

PMID:
28217856
40.

Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes.

Ratter JM, Rooijackers HM, Tack CJ, Hijmans AG, Netea MG, de Galan BE, Stienstra R.

Diabetes. 2017 Apr;66(4):1052-1061. doi: 10.2337/db16-1091. Epub 2017 Jan 23.

41.

Personalized glucose-insulin model based on signal analysis.

Goede SL, de Galan BE, Leow MKS.

J Theor Biol. 2017 Apr 21;419:333-342. doi: 10.1016/j.jtbi.2016.12.018. Epub 2016 Dec 28.

PMID:
28039012
42.

Extreme genomic erosion after recurrent demographic bottlenecks in the highly endangered Iberian lynx.

Abascal F, Corvelo A, Cruz F, Villanueva-Cañas JL, Vlasova A, Marcet-Houben M, Martínez-Cruz B, Cheng JY, Prieto P, Quesada V, Quilez J, Li G, García F, Rubio-Camarillo M, Frias L, Ribeca P, Capella-Gutiérrez S, Rodríguez JM, Câmara F, Lowy E, Cozzuto L, Erb I, Tress ML, Rodriguez-Ales JL, Ruiz-Orera J, Reverter F, Casas-Marce M, Soriano L, Arango JR, Derdak S, Galán B, Blanc J, Gut M, Lorente-Galdos B, Andrés-Nieto M, López-Otín C, Valencia A, Gut I, García JL, Guigó R, Murphy WJ, Ruiz-Herrera A, Marques-Bonet T, Roma G, Notredame C, Mailund T, Albà MM, Gabaldón T, Alioto T, Godoy JA.

Genome Biol. 2016 Dec 14;17(1):251.

43.

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye JE, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier JY, Galan B, Reynes J, Reuzeau JC, Bedbrook A, Granier S, Adnet PA, Amouyal M, Alomène B, Bernard PL, Berr C, Caimmi D, Claret PG, Costa DJ, Cristol JP, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot MC, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti MP, Bobia X, Boegner C, Boichot S, Bonnin HY, Bouly S, Boubakri C, Bourrain JL, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet AL, Courrouy-Michel MC, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy JM, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham AY, Gouzi F, Gressard F, Gris JC, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise MS, Lemaitre JM, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert CM, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou MP, Pasquié JL, Patte K, Perrey S, Pers YM, Portejoie F, Pujol JL, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso JP, Rivier F, Robine JM, Rolland C, Royère E, Sablot D, Savy JL, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J.

J Frailty Aging. 2016;5(4):233-241.

PMID:
27883170
44.

Engineering Mycobacterium smegmatis for testosterone production.

Fernández-Cabezón L, Galán B, García JL.

Microb Biotechnol. 2017 Jan;10(1):151-161. doi: 10.1111/1751-7915.12433. Epub 2016 Nov 17.

45.

Mycobacterium smegmatis is a suitable cell factory for the production of steroidic synthons.

Galán B, Uhía I, García-Fernández E, Martínez I, Bahíllo E, de la Fuente JL, Barredo JL, Fernández-Cabezón L, García JL.

Microb Biotechnol. 2017 Jan;10(1):138-150. doi: 10.1111/1751-7915.12429. Epub 2016 Nov 2.

46.

Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives.

de Galan BE.

Patient Prefer Adherence. 2016 Oct 17;10:2097-2106. eCollection 2016. Review.

47.

A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers.

Engwerda EEC, Tack CJ, de Galan BE.

Diabetes Res Clin Pract. 2016 Nov;121:86-90. doi: 10.1016/j.diabres.2016.09.001. Epub 2016 Sep 8.

PMID:
27662042
48.

Analysis and modelling of predation on biofilm activated sludge process: Influence on microbial distribution, sludge production and nutrient dosage.

Revilla M, Galán B, Viguri JR.

Bioresour Technol. 2016 Nov;220:572-583. doi: 10.1016/j.biortech.2016.08.107. Epub 2016 Aug 31.

PMID:
27614580
49.

Cerebral blood flow response to hypoglycemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycemia.

Wiegers EC, Becker KM, Rooijackers HM, von Samson-Himmelstjerna FC, Tack CJ, Heerschap A, de Galan BE, van der Graaf M.

J Cereb Blood Flow Metab. 2017 Jun;37(6):1994-2001. doi: 10.1177/0271678X16658914. Epub 2016 Jan 1.

50.

Genome sequence of the olive tree, Olea europaea.

Cruz F, Julca I, Gómez-Garrido J, Loska D, Marcet-Houben M, Cano E, Galán B, Frias L, Ribeca P, Derdak S, Gut M, Sánchez-Fernández M, García JL, Gut IG, Vargas P, Alioto TS, Gabaldón T.

Gigascience. 2016 Jun 27;5:29. doi: 10.1186/s13742-016-0134-5.

Supplemental Content

Support Center